Rang	Name	Position
1	Mr. David A. Ricks	Chairman, President & CEO
2	Mr. Lucas E. Montarce	Executive VP & CFO
3	Dr. Daniel M. Skovronsky M.D., Ph.D.	Chief Scientific & Product Officer and President of Lilly Research Laboratories
4	Ms. Anat Hakim J.D.	Executive VP, General Counsel & Secretary
5	Mr. Jacob S. Van Naarden	Executive VP, President of Lilly Oncology & Head of Corporate Business Development
6	Mr. Donald A. Zakrowski	Senior VP of Finance & Chief Accounting Officer
7	Mr. Diogo Rau	Executive VP and Chief Information & Digital Officer
8	Mr. Michael Czapar	Senior Vice President of Investor Relations
9	Mr. Eric Dozier	Executive VP & Chief People Officer
10	Mr. Ilya Yuffa	Executive VP and President of Lilly USA & Global Customer Capabilities

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Lilly Endowment Inc	10,14%	100,88 Mrd. USD
2	BlackRock Inc	7,45%	74,09 Mrd. USD
3	Vanguard Capital Management, LLC	5,99%	59,56 Mrd. USD
4	PNC Financial Services Group Inc	5,76%	57,29 Mrd. USD
5	State Street Corp	4,00%	39,75 Mrd. USD
6	FMR Inc	2,96%	29,40 Mrd. USD
7	Vanguard Portfolio Management, LLC	2,35%	23,41 Mrd. USD
8	Capital Research Global Investors	2,34%	23,30 Mrd. USD
9	Geode Capital Management, LLC	2,27%	22,54 Mrd. USD
10	Capital World Investors	1,78%	17,75 Mrd. USD
11	Morgan Stanley - Brokerage Accounts	1,73%	17,23 Mrd. USD
12	T. Rowe Price Associates, Inc.	1,57%	15,62 Mrd. USD
13	JPMorgan Chase & Co	1,54%	15,29 Mrd. USD
14	NORGES BANK	1,29%	12,81 Mrd. USD
15	Bank of America Corp	1,25%	12,42 Mrd. USD
16	Wellington Management Company LLP	1,23%	12,28 Mrd. USD
17	State Farm Mutual Automobile Ins Co	1,21%	12,01 Mrd. USD
18	PRIMECAP Management Company	1,03%	10,24 Mrd. USD
19	Northern Trust Corp	0,99%	9,85 Mrd. USD
20	UBS Asset Mgmt Americas Inc	0,79%	7,89 Mrd. USD